PLI Stock

Considerable losses and extended timelines for drug approval are keeping ProMetic Life Sciences (Pro... Read More

Echelon Wealth Partners analyst Douglas Loe says ProMetic Life Sciences (ProMetic Life Sciences Stoc... Read More

It looks like fans of Prometic Life Sciences (Prometic Life Sciences Stock Quote, Chart TSX:PLI) are... Read More

Analyst Douglas Loe of Echelon Wealth Partners has lowered his rating from “Speculative Buy” to ... Read More

A new development for ProMetic Life Sciences (ProMetic Life Sciences Stock Quote, Chart TSX:PLI) has... Read More

Biopharm company ProMetic Life Sciences (ProMetic Life Sciences Stock Quote, Chart TSX:PLI) announce... Read More